Court Opinion

ID: 4693046
Source: CourtListenerOpinion
Date Created: 2021-06-04 19:01:32.015753+00
Date Added: 2024-06-11T08:05:20.286186
License: Public Domain

NOT RECOMMENDED FOR PUBLICATION
                                 File Name: 21a0275n.06

                                         Case No. 20-2128

                           UNITED STATES COURT OF APPEALS
                                FOR THE SIXTH CIRCUIT
                                                                                     FILED
                                                                               Jun 04, 2021
                                                        )                  DEBORAH S. HUNT, Clerk
UNITED STATES OF AMERICA and STATE
                                                        )
OF MICHIGAN, ex rel.,
                                                        )
       Plaintiffs-Relators,                             )         ON APPEAL FROM THE
                                                        )         UNITED STATES DISTRICT
ASHWANI SHEORAN, RPh,                                   )         COURT FOR THE EASTERN
       Plaintiff-Relator/Appellant,                     )         DISTRICT OF MICHIGAN
                                                        )
v.                                                      )
                                                        )
WAL-MART STORES EAST, LP, TOI                           )                              OPINION
WALKER;   DOUG    HENGER;   ALFRED                      )
RODRIGUEZ; RICHARD LOCKARD, M.D.,                       )
                                                        )
       Defendants-Appellees.
                                                        )

BEFORE: CLAY, McKEAGUE, and LARSEN, Circuit Judges.

       McKEAGUE, Circuit Judge. In 2013, Ashwani Sheoran filed a sealed complaint under

the False Claims Act and the Michigan Medicaid False Claims Act alleging that a doctor was

writing improper prescriptions for high dosages of opiates and that Walmart was filling those

prescriptions. After five years, the United States and State of Michigan declined to intervene and

prosecute the case on Sheoran’s behalf, and the district court unsealed the complaint. The district

court granted the defendants’ motions to dismiss and denied Sheoran’s motion for reconsideration.

Sheoran challenges the district court’s grant of the motions to dismiss, its alleged failure to address
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

claims under the Michigan Medicaid False Claims Act, and its decision not to hold oral argument

for the motions.

         We find Sheoran’s arguments to be without merit and AFFIRM the judgment of the district

court.

                                                   I

         In April 2012, Sheoran began working as a full-time floater pharmacist for Walmart in

Michigan, which meant that he would work at different pharmacies around the state. In July 2012,

Sheoran arrived to work at a Walmart in Bad Axe, Michigan and observed a line of roughly ten

customers waiting for the pharmacy to open, all of whom were patients of Dr. Richard Lockard.

Sheoran claims that they all presented prescriptions for very high doses of opiates, so high that one

patient would have died had he or she “actually taken” the prescription.

         Then, in August 2012, while working at the same Walmart, Sheoran claims he received

large numbers of opiate prescriptions from Dr. Lockard’s office and declined to fill them due to

their high doses. Sometime afterwards, Sheoran obtained one unidentified patient’s “Medical

Expenses Summary,” which listed that patient’s prescriptions and costs over a five-year period.

Sheoran concluded that because the cost to the patient was $1-2 for many of the prescriptions, they

must have been submitted to Medicare or Medicaid for payment, which would potentially trigger

liability under the False Claims Act. Claiming that this Medical Expenses Summary was one

example of thousands, he brought his concerns to his supervisor. Walmart investigated and found

that the pharmacy was not following Walmart’s internal procedures for filling faxed prescriptions

but did not conclude that any laws or regulations were violated. After a meeting where Sheoran

was reprimanded for stealing the Medical Expenses Summary (later attached to his complaint) in

violation of Walmart’s policies, he was fired on January 21, 2013.

                                                -2-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

       On February 11, 2013, about a month after he was terminated, Sheoran filed a complaint

under seal alleging False Claims Act (“FCA”) violations against Walmart, three individual

employees of Walmart, and three doctors. After amending his complaint, Sheoran alleged (1)

presentation of false claims under the FCA and Michigan Medicaid False Claims Act

(“MMFCA”); (2) use of false records under the FCA and MMFCA; (3) conspiracy to violate the

FCA; and (4) retaliation under the FCA by Walmart. After five years, the United States and State

of Michigan declined to intervene in the case, so the district court unsealed the complaint on March

7, 2018. The Walmart defendants and one of the doctors, Dr. Lockard, moved to dismiss, and the

district court granted their motions on August 20, 2019. Sheoran moved for reconsideration, which

the district court denied on September 28, 2020. This appeal followed.

                                                   II

       Sheoran challenges the decisions below in three ways. The bulk of his briefing focuses on

whether the district court was incorrect in granting the motions to dismiss. He also argues that that

the district court erred by failing to include his MMFCA claims in its summary of claims in the

orders and that the district court abused its discretion by waiving oral argument on the motions.

We address each argument in turn.1

1
  Sheoran’s statement of issues does not address whether the district court correctly granted the
motions to dismiss, and instead addresses only his MMFCA and oral argument claims. Therefore,
we could restrict our analysis to those two claims alone because Federal Rule of Appellate
Procedure 28(a)(5) specifies that “[t]he appellant’s brief must contain” the issues presented in the
statement of issues; therefore, issues not included may be dismissed as forfeited. See United States
v. Calvetti, 836 F.3d 654, 664 (6th Cir. 2016). Nonetheless, given its importance on appeal, we
will address whether the district court correctly granted the motions to dismiss. To the extent that
Sheoran’s briefing raises other arguments, many of which are undeveloped and presented in only
a paragraph or two, we deem them forfeited because of Sheoran’s perfunctory treatment of them
and because they were not included in Sheoran’s statement of issues. See id.; United States v.
Johnson, 430 F.3d 383, 397 (6th Cir. 2005); United States v. Burton, 828 F. App’x 290, 293 n.1
(6th Cir. 2020); Barrett v. Detroit Heading, LLC, 311 F. App’x 779, 796 (6th Cir. 2009).
                                                -3-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

        A. Dismissal for failure to state a claim

        We review a district court’s dismissal for failure to state a claim de novo. Yuhasz v. Brush

Wellman, Inc., 341 F.3d 559, 562 (6th Cir. 2003). To survive a motion to dismiss, a complaint

must contain more than “labels and conclusions,” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555

(2007), and we may reject “mere assertions and unsupported or unsupportable conclusions.”

Sanderson v. HCA-The Healthcare Co., 447 F.3d 873, 876 (6th Cir. 2006). Complaints brought

under the FCA require plaintiffs to satisfy the particularity requirements of Federal Rule of Civil

Procedure 9(b).     Yuhasz, 341 F.3d at 563.           This heightened standard requires that the

plaintiff “allege the time, place, and content of the alleged misrepresentation . . . [;] the fraudulent

scheme; the fraudulent intent of the defendants; and the injury resulting from the fraud.” United

States ex rel. Bledsoe v. Cmty. Health Sys., Inc., 342 F.3d 634, 643 (6th Cir. 2003) (quoting Coffey

v. Foamex L.P., 2 F.3d 157, 161–62 (6th Cir. 1993)).

        1. False claims and false records

        Sheoran’s first two counts allege that the defendants knowingly presented false claims to

the government and knowingly made false records for use in those claims. To establish a claim

under the FCA, a plaintiff must allege that (i) the defendant presented a claim of payment to the

government, (ii) the claim was false or fraudulent, (iii) the defendant knew it was false or

fraudulent, and (iv) the false claim was material to the government’s payment. See United States

ex rel. Sheldon v. Kettering Health Network, 816 F.3d 399, 408 (6th Cir. 2016). Sheoran’s

complaint falls short on all four elements.

        a. Presentment

        A critical component of an FCA complaint is the allegation that a claim for payment was

presented to a government entity. See Sanderson, 447 F.3d at 878 (describing presentment as the

                                                 -4-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

“sine qua non of a False Claims Act violation”). Under Rule 9(b), specifics on presentment are

required, such as the types of employees involved and the “specific dates” underlying the claims.

United States ex rel. Bledsoe v. Cmty. Health Sys., Inc., 501 F.3d 493, 515 (6th Cir. 2007);

Sanderson, 447 F.3d at 877–78.

       Sheoran claims that Exhibit A of the complaint, the Medical Expenses Summary,

establishes presentment, but that exhibit is simply a summary of one unidentified patient’s

prescriptions and expenses. Nothing about the document indicates that any of the entries were

presented to a government agency. Sheoran argues that because some of the payments were for

$1-2, the patient must have received government reimbursement through Medicare or Medicaid.

But Rule 9(b) requires far more than mere speculation. See Sanderson, 447 F.3d at 877 (noting

that plaintiffs cannot simply allege that claims “must have been submitted, were likely submitted,

or should have been submitted to the Government”) (quoting United States ex rel. Clausen v. Lab’y

Corp. of Am., Inc., 290 F.3d 1301, 1311 (11th Cir. 2002)). As the district court noted, many

reasons could exist for the low costs to the patient, such as subsidizing by private insurance

companies. Because this bare-bones assertion must be rejected, Sheoran cannot satisfy the

presentment element of his FCA claims.

       b. Falsity

       The second element of an FCA claim is that the claim submitted must be “false or

fraudulent.” 31 U.S.C. § 3729(a)(1)(A), (B). Again, Sheoran relies solely on Exhibit A to satisfy

this element, claiming that the “high doses” listed “would kill the person” if taken as prescribed.

But we must reject mere “conclusions” and “naked assertions” in a complaint. See Ashcroft v.

Iqbal, 556 U.S. 662, 678 (2009). Exhibit A simply lists one patient’s prescriptions and expenses

and contains no other medical information, and Sheoran offers none in his complaint. It is

                                               -5-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

impossible to evaluate whether the doses were too high without more information regarding the

patient’s medical history or needs. Therefore, there is no way to conclude that Exhibit A

establishes falsity.

        c. Knowledge

        Next, Sheoran must sufficiently allege that the defendants “knowingly” presented false

claims or “knowingly” created false records for false claims. 31 U.S.C. § 3729(a)(1)(A), (B); see

id. § 3729(b)(1). This is a high bar, requiring “that a defendant knows of, or ‘acts in deliberate

ignorance’ or ‘reckless disregard’ of, the fact that he is involved in conduct that violates a legal

obligation to the United States.”      United States ex rel. Harper v. Muskingum Watershed

Conservancy Dist., 842 F.3d 430, 437 (6th Cir. 2016) (quoting 31 U.S.C. § 3729(b)). Once again,

even assuming that the prescriptions in Exhibit A were submitted to the government, nothing in

those prescriptions would indicate to Walmart that they were illegal, false, or fraudulent.

Sheoran’s complaint does not describe how Walmart could have concluded the prescriptions were

false or fraudulent in some way, so he fails to satisfy this element.

        d. Materiality

        Finally, Sheoran must show that the alleged misrepresentation made to the government was

“material” to the government’s decision to reimburse the claim. Universal Health Servs., Inc. v.

United States, 136 S. Ct. 1989, 2001 (2016). This “demanding” standard should go “to the very

essence of the bargain,” as the FCA was not enacted to punish “garden-variety” violations. Id. at

2001–03 & n.5. Assuming that Walmart actually submitted the claims in Exhibit A to the

government, the government would have had access to the same knowledge that Walmart had

regarding the allegedly “high doses” of controlled substances prescribed. Even if we accept as

true Sheoran’s representation that the prescriptions in Exhibit A were submitted to the government

                                                -6-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

and that the exhibit, on its face, shows false or fraudulent claims, then the government’s decision

to pay those claims despite that knowledge “is very strong evidence that those requirements are

not material.” Id. at 2003. Therefore, Sheoran fails to satisfy this element.

       2. Conspiracy

       Sheoran’s third count of FCA conspiracy against Walmart falls with the two preceding

substantive claims. Conspiracy under the FCA is derivative of the substantive claims of submitting

a false claim to the government or creating a false record. See 31 U.S.C. § 3729(a)(1)(C); United

States ex rel. Crockett v. Complete Fitness Rehab., Inc., 721 F. App’x 451, 459 (6th Cir. 2018).

As we have concluded in the preceding section, Sheoran’s first two counts failed to meet the

pleading standards of Rules 12(b)(6) and 9(b), which means his conspiracy claim fails as well. See

Crockett, 721 F. App’x at 459 (holding that the plaintiff’s “inability to show that false claims were

actually submitted to the government means that her . . . false-claims-conspiracy counts are

likewise subject to dismissal, because the existence of such false claims is a precondition to [this]

theory”).

       3. Retaliation

       Finally, the district court correctly dismissed Sheoran’s retaliation claim. FCA retaliation

claims are not subject to Rule 9(b)’s heightened standards, see id. at 460, but “a plaintiff must

show: (1) he engaged in a protected activity; (2) his employer knew that he engaged in the

protected activity; and (3) his employer discharged or otherwise discriminated against the

employee as a result of the protected activity.” Yuhasz, 341 F.3d at 566. Sheoran’s retaliation

claim fails because he failed to plead that Walmart knew he was pursuing an FCA action.

Employees “must make clear their intentions of bringing or assisting in an FCA action” to show

retaliation. Id. at 568. Sheoran claims that he told his superiors about the allegedly false

                                                -7-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

prescriptions, but that is not enough. Even when an employee tells their employer that they have

witnessed illegal conduct and that other companies have incurred FCA liability for similar conduct,

that fails to establish that an employee is pursuing an FCA action. Id. at 567; McKenzie v.

BellSouth Telecomms., Inc., 219 F.3d 508, 518 (6th Cir. 2000) (noting that telling an employer

about their alleged regulatory violations was not sufficient to satisfy this requirement). Therefore,

Sheoran’s retaliation claim was properly dismissed.

        B. Michigan Medicaid False Claims Act

        Next, Sheoran claims that the district court erred by failing to address his MMFCA claims

when it summarized Sheoran’s claims in its order. But first, contrary to Sheoran’s assertions on

appeal, two of the four claims in his complaint were not brought under the MMFCA at all.

Sheoran’s conspiracy and retaliation claims referenced only federal FCA provisions. There can

be no error in the district court’s failure to discuss claims that did not exist.

        Second, the district court addressed the other two claims, recognizing that Sheoran brought

them under “the Michigan Medicaid False Claims Act” as well as the federal FCA. The district

court’s analysis applied to both sets of claims, and it dismissed the state law claims along with the

federal ones.

        To the extent Sheoran argues that the MMFCA claims should have been analyzed

differently than the federal FCA claims, that argument is contradicted by both the proceedings

below as well as precedent. Neither the complaint nor the motion to dismiss briefing identified

any distinctions between the FCA and MMFCA in this case. And that makes sense, because the

FCA and MMFCA are identical in every relevant respect here and are frequently analyzed in

tandem. See, e.g., Hendricks v. Bronson Methodist Hosp., Inc., No. 1:13–CV–294, 2014 WL

3752917, at *2–7 (W.D. Mich. July 30, 2014) (analyzing FCA and MMFCA claims together). The

                                                  -8-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

federal FCA prohibits “knowingly present[ing]” a “false or fraudulent claim” as well as

“knowingly mak[ing]” a “false record” “material” to such a claim, 31 U.S.C. § 3729(a)(1), and the

MMFCA contains two substantially similar provisions, see Mich. Comp. Laws § 400.607(1), (2);

Hendricks, 2014 WL 3752917, at *2. Therefore, there was no error in the district court analyzing

both sets of claims the same way.

       C. Oral argument

       Sheoran suggests that the district court issued “confusing” orders, dismissed his claims

“without a hearing or clear understanding of the factual and legal issues,” and thereby erred in

waiving oral argument for the motions. We review whether a district court impermissibly decided

a motion without oral argument for an abuse of discretion. Mann v. Conlin, 22 F.3d 100, 103 (6th

Cir. 1994).

       We see no abuse of discretion here. The Federal Rules of Civil Procedure and the district

court’s local rules expressly permit deciding motions without oral argument. Fed. R. Civ. P. 78(b);

E.D. Mich. Loc. R. 7.1(f). And doing so serves many valuable functions for the judiciary, such as

allowing district courts to “effectively manage very crowded case dockets,” especially in instances

where “the legal issues are abundantly clear and . . . firmly settled.” Yamaha Corp of Am. v.

Stonecipher’s Baldwin Pianos & Organs, Inc., 975 F.2d 300, 301 n.1 (6th Cir. 1992). Deciding

motions on the briefs also “encourages improved brief writing” and “forces the parties to

thoroughly research the legal basis on which their positions rest.” Id. We routinely approve of a

district court’s decision to decide motions without oral argument and see no reason to reject the

court’s decision to do so here.

       In response, Sheoran claims the orders were “very confusing” and that the district court

failed to “understand the complex issues in this case.” But as the analysis above demonstrates,

                                               -9-
Case No. 20-2128, United States ex rel. Sheoran v. Wal-Mart Stores East

this was a straightforward FCA case that was properly decided on the briefs. And the specific

claims that Sheoran makes regarding the district court’s allegedly “confusing” analysis do not

show an abuse of discretion. For example, Sheoran claims that the district court failed to note that

FCA liability can be established if claims are submitted “to certain third parties acting on the

Government’s behalf” and not just to the government itself. Sheoran’s statement of the law is

accurate, see Cochise Consultancy, Inc. v. United States ex rel. Hunt, 139 S. Ct. 1507, 1510 (2010),

but irrelevant. Sheoran did not claim that the payments were submitted to third parties, so the

district court had no reason to discuss that aspect of the law. Later, Sheoran claims that the district

court’s use of the phrase “appears to allege” was an “admission” that confirmed “the district court

was not confident” about what Sheoran’s complaint was alleging and that oral argument was

necessary “to clear up the court’s confusion.” We reject Sheoran’s invitation to parse the words

of the district court so finely or conclude that the district court was confused based on its use of

that phrase. In sum, Sheoran’s arguments have no merit and fail to show an abuse of discretion in

the district court’s decision to decide the motions without oral argument.

                                                 III

       We AFFIRM the judgment of the district court.

                                                - 10 -